Skip to main content
Clinical Trials/NL-OMON43614
NL-OMON43614
Completed
Phase 2

Effect of Health games on Cognitive Function in Parkinson*s Disease - Health game for cognition

Medisch Universitair Ziekenhuis Maastricht0 sites222 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
neurologische aandoening
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
222
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • \- Diagnosis of idiopathic PD according to the UK Brain Bank Criteria
  • \- Cognitive impairment at baseline in line with the Level 1 criteria for MCI and a cut\-off of 1\.5 SD below the normative mean.
  • \- Aged between 40 and 75 years old.
  • \- Not receiving any other cognitive therapy or intensified physical activity during the study
  • \- Relatively stable dopaminergic medication (and relatively stable stimulation parameters in case of a neurostimulator) within last three months, or the change in medication does not influence cognition (LED change of less than 50% increase or decrease).
  • \- Must have access to internet.

Exclusion Criteria

  • \- Hoehn \& Yahr stage 4 or 5
  • \- Advanced problems in cognitive functioning: Montreal Cognitive Assessment (MoCa) \< 19/30
  • \- Habitual gamers (\>1hr games/week in preceding year)
  • \- Active depression or psychosis and/or treatment with anti\-depressant or anti\-psychotic drugs which influences cognition.
  • \- Medication interfering with cognition including anticholinergic medication, benzodiazepines not used as sleep medication and stimulants (i.e. methylphenidate)
  • \- Premorbid intelligence \< 86 based on the Dutch National Adult Reading test (NART)
  • \- Severe auditory or visual deficits
  • \- History of active thyroid disease, stroke with residual deficits, severe hypertension or diabetes or head trauma interfering in cognition
  • \- (MRI substudy exclusion: any piece of metal in the body, and/or claustrophobia).

Outcomes

Primary Outcomes

Not specified

Similar Trials